{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.4:c.6059T>C",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "T",
            "alt": "C",
            "position": "6059"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "T6059>C (I2020T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 and SH-SY5Y",
        "Description": "HEK293 cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FCS and antibiotics. SH-SY5Y cells were cultured in DMEM nutrient mixture F-12 HAM supplemented with 10% FCS, and antibiotics."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "I2020T LRRK2 showed higher susceptibility to post-translational degradation compared to wild-type LRRK2, with protein levels significantly lower in untreated conditions."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed with multiple cell lines and clones (HEK293 and SH-SY5Y)."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control for comparison with I2020T mutant."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected cells expressing only endogenous LRRK2 were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels comparable to wild-type LRRK2 under untreated conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression levels significantly lower than wild-type LRRK2 due to increased degradation.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Hydrogen Peroxide-Induced Apoptosis Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 and SH-SY5Y",
        "Description": "HEK293 and SH-SY5Y cells were transfected with WT or I2020T LRRK2 cDNA and treated with hydrogen peroxide to induce apoptosis."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "I2020T LRRK2-transfected cells showed a significantly higher percentage of apoptotic cells compared to WT LRRK2-transfected cells, indicating impaired protectivity against H2O2-induced apoptosis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed with multiple cell lines and clones (HEK293 and SH-SY5Y)."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Experiments were repeated with n=3 as indicated in statistical analysis."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control for comparison with I2020T mutant."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected cells expressing only endogenous LRRK2 were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Percentage of apoptotic cells significantly lower than untransfected cells, comparable to WT LRRK2-transfected cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Percentage of apoptotic cells similar to or higher than untransfected cells, indicating impaired protectivity.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Caspase-9 Activation Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells transfected with WT or I2020T LRRK2 cDNA were analyzed for caspase-9 activation after H2O2 treatment."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Higher molecular ratio of activated to inactive caspase-9 in I2020T LRRK2-transfected cells compared to WT LRRK2-transfected cells, indicating reduced protectivity against apoptosis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed with multiple transfections."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Experiments were repeated with n=3 as indicated in statistical analysis."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control for comparison with I2020T mutant."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected cells expressing only endogenous LRRK2 were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Molecular ratio of activated to inactive caspase-9 lower than untransfected cells, comparable to WT LRRK2-transfected cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Molecular ratio of activated to inactive caspase-9 higher than WT LRRK2-transfected cells, indicating impaired protectivity.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "LRRK2 Knockdown Experiment",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were co-transfected with WT LRRK2 cDNA and LRRK2-specific RNAi or control RNAi to assess the effect of protein level on apoptosis protectivity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "This assay focused on WT LRRK2 knockdown effects; specific results for I2020T variant not described in this context."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed with multiple transfections."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "WT LRRK2 with control RNAi was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected cells or cells with LRRK2-specific RNAi reducing protein levels were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Statistical method not specified for this specific assay in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability comparable to WT LRRK2-transfected cells without knockdown.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant reduction in cell viability due to decreased LRRK2 protein levels after knockdown.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}